Standout Papers

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a pha... 2017 2026 2020 2023 565
  1. Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study (2017)
    Luc Dirix, István Takács et al. Breast Cancer Research and Treatment

Immediate Impact

1 by Nobel laureates 10 from Science/Nature 56 standout
Sub-graph 1 of 19

Citing Papers

Natural killer cell therapies
2024 StandoutNature
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
5 intermediate papers

Works of Robert A. Somer being referenced

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
2017 Standout
Bispecific Minibodies Targeting HER2/neu and CD16 Exhibit Improved Tumor Lysis When Placed in a Divalent Tumor Antigen Binding Format
2004

Author Peers

Author Last Decade Papers Cites
Robert A. Somer 923 406 214 252 32 1.2k
Édith Borcoman 915 403 164 272 49 1.3k
Inge O. Baas 733 341 228 93 42 1.4k
Andy Sherrod 775 516 109 180 39 1.5k
Wolf‐Dietrich Beecken 422 263 164 180 24 1.0k
Claudia Lombardo 420 229 275 355 39 1.2k
Louise C. Connell 1174 338 106 367 31 1.5k
Ping Yang 1104 380 236 316 26 1.6k
Chan-Young Ock 1004 501 253 282 42 1.4k
Assuntina G. Sacco 749 560 273 139 59 1.7k
Delicia Carey 588 237 83 138 20 1.2k

All Works

Loading papers...

Rankless by CCL
2026